USPTO Grants Patent for Novel Therapeutics for Antibody-Cannabinoid Conjugates
Diverse Biotech Inc., an innovative developer in novel drug technology, today announced a pivotal advancement with its fully granted U.S. Patent No. 11,877,988 B2, which specifically covers innovative Antibody-Cannabinoid Conjugate Molecules.